Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm

Candida albicans (C. albicans) is the most frequent strain associated with cross-kingdom infections in the oral cavity. Clinical evidence shows the co-existence of Streptococcus mutans (S. mutans) and C. albicans in the carious lesions especially in children with early childhood caries (ECC) and dem...

Full description

Bibliographic Details
Main Authors: Yijun Li, Shan Huang, Jingyun Du, Minjing Wu, Xiaojing Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106231/full
_version_ 1797828877827964928
author Yijun Li
Yijun Li
Shan Huang
Jingyun Du
Minjing Wu
Xiaojing Huang
author_facet Yijun Li
Yijun Li
Shan Huang
Jingyun Du
Minjing Wu
Xiaojing Huang
author_sort Yijun Li
collection DOAJ
description Candida albicans (C. albicans) is the most frequent strain associated with cross-kingdom infections in the oral cavity. Clinical evidence shows the co-existence of Streptococcus mutans (S. mutans) and C. albicans in the carious lesions especially in children with early childhood caries (ECC) and demonstrates the close interaction between them. During the interaction, both S. mutans and C. albicans have evolved a complex network of regulatory mechanisms to boost cariogenic virulence and modulate tolerance upon stress changes in the external environment. The intricate relationship and unpredictable consequences pose great therapeutic challenges in clinics, which indicate the demand for de novo emergence of potential antimicrobial therapy with multi-targets or combinatorial therapies. In this article, we present an overview of the clinical significance, and cooperative network of the cross-kingdom interaction between S. mutans and C. albicans. Furthermore, we also summarize the current strategies for targeting cross-kingdom biofilm.
first_indexed 2024-04-09T13:11:26Z
format Article
id doaj.art-92a2d3ff993b4107abb42e1c61e4c08a
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-09T13:11:26Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-92a2d3ff993b4107abb42e1c61e4c08a2023-05-12T07:03:30ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-05-011310.3389/fcimb.2023.11062311106231Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilmYijun Li0Yijun Li1Shan Huang2Jingyun Du3Minjing Wu4Xiaojing Huang5Fujian Key Laboratory of Oral Diseases and Fujian Provincial Engineering Research Center of Oral Biomaterial and Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, ChinaDepartment of Endodontics, Stomatological Hospital of Xiamen Medical College, Xiamen, ChinaFujian Key Laboratory of Oral Diseases and Fujian Provincial Engineering Research Center of Oral Biomaterial and Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, ChinaFujian Key Laboratory of Oral Diseases and Fujian Provincial Engineering Research Center of Oral Biomaterial and Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, ChinaStomatological Hospital, Southern Medical University, Guangzhou, ChinaFujian Key Laboratory of Oral Diseases and Fujian Provincial Engineering Research Center of Oral Biomaterial and Stomatological Key Lab of Fujian College and University, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, ChinaCandida albicans (C. albicans) is the most frequent strain associated with cross-kingdom infections in the oral cavity. Clinical evidence shows the co-existence of Streptococcus mutans (S. mutans) and C. albicans in the carious lesions especially in children with early childhood caries (ECC) and demonstrates the close interaction between them. During the interaction, both S. mutans and C. albicans have evolved a complex network of regulatory mechanisms to boost cariogenic virulence and modulate tolerance upon stress changes in the external environment. The intricate relationship and unpredictable consequences pose great therapeutic challenges in clinics, which indicate the demand for de novo emergence of potential antimicrobial therapy with multi-targets or combinatorial therapies. In this article, we present an overview of the clinical significance, and cooperative network of the cross-kingdom interaction between S. mutans and C. albicans. Furthermore, we also summarize the current strategies for targeting cross-kingdom biofilm.https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106231/fullbiofilmCandida albicansStreptococcus mutanscross-kingdom interactiontherapeutic strategies
spellingShingle Yijun Li
Yijun Li
Shan Huang
Jingyun Du
Minjing Wu
Xiaojing Huang
Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
Frontiers in Cellular and Infection Microbiology
biofilm
Candida albicans
Streptococcus mutans
cross-kingdom interaction
therapeutic strategies
title Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
title_full Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
title_fullStr Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
title_full_unstemmed Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
title_short Current and prospective therapeutic strategies: tackling Candida albicans and Streptococcus mutans cross-kingdom biofilm
title_sort current and prospective therapeutic strategies tackling candida albicans and streptococcus mutans cross kingdom biofilm
topic biofilm
Candida albicans
Streptococcus mutans
cross-kingdom interaction
therapeutic strategies
url https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106231/full
work_keys_str_mv AT yijunli currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm
AT yijunli currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm
AT shanhuang currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm
AT jingyundu currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm
AT minjingwu currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm
AT xiaojinghuang currentandprospectivetherapeuticstrategiestacklingcandidaalbicansandstreptococcusmutanscrosskingdombiofilm